Brown-Forman (BF.B) has been added to several Russell indexes, including the Russell 2500, Russell 1000 Dynamic Index, and related value benchmarks, a shift that can influence how many institutional investors track the stock.

Brown-Forman’s recent index additions come after a mixed stretch, with the share price up 4.89% over 30 days but down 2.21% over 90 days, and the 1-year total shareholder return declining 4.31% and 5-year total shareholder return declining 60.50%. This points to short-term momentum improving against a much weaker longer-term record.

If you are reassessing your watchlist after Brown-Forman’s move into new indexes, it could be a good moment to broaden your search and look at 20 top founder-led companies

With Brown-Forman trading at a discount to recent analyst targets and some investors arguing the stock is materially undervalued, you need to decide whether there is still a buying opportunity here or whether the market is already pricing in future growth.

Most Popular Narrative: 6.7% Undervalued

The most followed Brown-Forman narrative places fair value at $28.03, slightly above the last close of $26.16, framing the stock as modestly undervalued on a discounted cash flow view using a 7.11% discount rate.

Brown-Forman is realizing strong organic net sales growth in emerging international markets (25%+ in some regions like Brazil and Mexico), driven by strategic focus on premiumization and distribution of flagship and super-premium brands, which positions the company to benefit as the global middle class expands, supporting future revenue and geographic diversification, which should help offset U.S. market uncertainty.

Curious how modest revenue growth, slightly wider margins and a recalibrated earnings multiple all combine to support that fair value? The underlying assumptions are more tightly balanced than they look at first glance.

Result: Fair Value of $28.03 (UNDERVALUED)

However, Brown-Forman’s narrative could still be knocked off course if spirits demand in key developed markets keeps softening, or if cost pressures further squeeze already tighter margin expectations.

Next Steps

With Brown-Forman’s mixed track record and evolving narrative, do you see more risk or more upside here? Act while the data is fresh and weigh both sides by checking 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Brown-Forman?

Do not stop with Brown-Forman; widen your watchlist using the Simply Wall St screener and quickly surface fresh ideas that match the way you like to invest.

• Spot potential value opportunities early by scanning a focused set of 43 high quality undervalued stocks before the crowd pays attention.
• Prioritize resilience by filtering for solid balance sheet and fundamentals stocks screener (46 results) so you are not relying on companies with fragile finances.
• Get ahead of the market by combing through a screener containing 18 high quality undiscovered gems that most investors are still overlooking.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.